64 related articles for article (PubMed ID: 22098992)
1. Re: Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.
Atala A
J Urol; 2011 Apr; 185(4):1533-4. PubMed ID: 22098992
[No Abstract] [Full Text] [Related]
2. Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.
Chen H; Yong W; Hinds TD; Yang Z; Zhou Y; Sanchez ER; Shou W
J Biol Chem; 2010 Sep; 285(36):27776-84. PubMed ID: 20605780
[TBL] [Abstract][Full Text] [Related]
3. Physiological role for the cochaperone FKBP52 in androgen receptor signaling.
Cheung-Flynn J; Prapapanich V; Cox MB; Riggs DL; Suarez-Quian C; Smith DF
Mol Endocrinol; 2005 Jun; 19(6):1654-66. PubMed ID: 15831525
[TBL] [Abstract][Full Text] [Related]
4. Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).
Sivils JC; Storer CL; Galigniana MD; Cox MB
Curr Opin Pharmacol; 2011 Aug; 11(4):314-9. PubMed ID: 21511531
[TBL] [Abstract][Full Text] [Related]
5. Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice.
Hartmann J; Wagner KV; Dedic N; Marinescu D; Scharf SH; Wang XD; Deussing JM; Hausch F; Rein T; Schmidt U; Holsboer F; Müller MB; Schmidt MV
Psychoneuroendocrinology; 2012 Dec; 37(12):2009-21. PubMed ID: 22641006
[TBL] [Abstract][Full Text] [Related]
6. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
7. Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias.
Beleza-Meireles A; Barbaro M; Wedell A; Töhönen V; Nordenskjöld A
Reprod Biol Endocrinol; 2007 Mar; 5():8. PubMed ID: 17343741
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor mRNA measured by quantitative real time PCR is decreased in the urethral mucosa of patients with middle idiopathic hypospadias.
Silva TS; Richeti F; Cunha DP; Amarante AC; de Souza Leão JQ; Longui CA
Horm Metab Res; 2013 Jul; 45(7):495-500. PubMed ID: 23386417
[TBL] [Abstract][Full Text] [Related]
9. FKBP52.
Davies TH; Sánchez ER
Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
[TBL] [Abstract][Full Text] [Related]
10. Development of the external genitalia.
Cunha GR; Baskin LS
Differentiation; 2020; 112():7-9. PubMed ID: 31881402
[No Abstract] [Full Text] [Related]
11. Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity.
Hong J; Kim ST; Tranguch S; Smith DF; Dey SK
Reproduction; 2007 Feb; 133(2):395-403. PubMed ID: 17307907
[TBL] [Abstract][Full Text] [Related]
12. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
13. Yeast-based reporter assays for the functional characterization of cochaperone interactions with steroid hormone receptors.
Balsiger HA; Cox MB
Methods Mol Biol; 2009; 505():141-56. PubMed ID: 19117143
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal dynamics of androgen signaling underlie sexual differentiation and congenital malformations of the urethra and vagina.
Larkins CE; Enriquez AB; Cohn MJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7510-E7517. PubMed ID: 27821748
[TBL] [Abstract][Full Text] [Related]
15. FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform.
Yang Z; Wolf IM; Chen H; Periyasamy S; Chen Z; Yong W; Shi S; Zhao W; Xu J; Srivastava A; Sánchez ER; Shou W
Mol Endocrinol; 2006 Nov; 20(11):2682-94. PubMed ID: 16873445
[TBL] [Abstract][Full Text] [Related]
16. Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra.
Kim KS; Liu W; Cunha GR; Russell DW; Huang H; Shapiro E; Baskin LS
Cell Tissue Res; 2002 Feb; 307(2):145-53. PubMed ID: 11845321
[TBL] [Abstract][Full Text] [Related]
17. Identification of domains of c-Jun mediating androgen receptor transactivation.
Wise SC; Burmeister LA; Zhou XF; Bubulya A; Oberfield JL; Birrer MJ; Shemshedini L
Oncogene; 1998 Apr; 16(15):2001-9. PubMed ID: 9591784
[TBL] [Abstract][Full Text] [Related]
18. Evidence that lack of ligand-binding domain correlates with nuclear distribution of unliganded human androgen receptor and loss of transactivation activity.
Suzuki N; Imai A
Gynecol Endocrinol; 2011 Nov; 27(11):940-3. PubMed ID: 21501000
[TBL] [Abstract][Full Text] [Related]
19. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
[TBL] [Abstract][Full Text] [Related]
20. FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells.
López E; Berna-Erro A; Salido GM; Rosado JA; Redondo PC
Biochim Biophys Acta; 2013 Mar; 1833(3):652-62. PubMed ID: 23228564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
